Control of glycogen synthesis in health and disease
- 1 January 1987
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 3 (1) , 127-161
- https://doi.org/10.1002/dmr.5610030107
Abstract
Investigations in our laboratory have shown that the activity of glycogen synthase phosphatase in the liver is shared by at least two functionally distinct proteins: a G-component, which is tightly associated with glycogen particles, and a soluble S-component. Most preparations of glycogen synthase-b that are isolated from the liver of fed glucagon-treated animals require the presence of both components in order to be converted to synthase-a. The G-component is subject to control mechanisms that do not affect the S-component. Its activity is strongly inhibited by phosphorylase-a. This feature explains why glycogen synthesis and glycogenolysis do not normally occur simultaneously, except in the glycogen-depleted liver, where a futile cycle may occur. Experiments in vitro have shown that a minimal glycogen concentration is required to ensure the interaction between the G-component and phosphorylase-a. The G-component is also selectively inhibited by Ca2+, and the magnitude of this inhibition depends markedly on the glycogen concentration. The latter inhibition is probably one of the mechanisms by which cyclic adenosine monophosphate (cAMP)-independent glycogenolytic agents achieve the inactivation of glycogen synthase in the liver. Glucocorticoid hormones and insulin are required for the induction and/or maintenance of the G-component in the liver. During the development of the fetal rat, glucocorticoids induce the G-component in the liver. This is an essential event in the glucocorticoid-triggered deposition of glycogen in the fetal liver. A functional adrenal cortex is also required in the adult animal to prevent a loss of the capacity for hepatic glycogen storage during starvation. The latter capacity depends on the concentration of functional G-component in the liver. Chronic diabetes causes a similar functional loss. However, the effect of glucocorticoids is not mediated by a putative secretion of insulin.Keywords
This publication has 140 references indexed in Scilit:
- Effect of phosphorylation by different protein kinases on the behaviour of glycogen synthase as a substrate for hepatic synthase phosphatasesBiochemical and Biophysical Research Communications, 1986
- The deinhibitor protein: Regulation by phosphorylation-dephosphorylationBiochemical and Biophysical Research Communications, 1984
- On the mechanism of hepatic glycogenolysis induced by anoxia or cyanideBiochemical and Biophysical Research Communications, 1983
- Coordinated feedback regulation of muscle glycogen metabolism: inhibition of purified phosphorylase phosphatase by glycogenBiochemical and Biophysical Research Communications, 1983
- Morphological and biochemical observations on hepatic glycogen metabolism in mice on a controlled feeding scheduleDigestive Diseases and Sciences, 1982
- Release and activation of phosphorylase phosphatase upon rupture of organelles from rat liverBiochemical and Biophysical Research Communications, 1982
- The role of phosphorylase in the inhibitory effect of EDTA and ATP on liver glycogen synthase phosphataseBiochemical and Biophysical Research Communications, 1979
- An absolute requirement for insulin in the control of hepatic glycogenesis by glucoseBiochemical and Biophysical Research Communications, 1973
- The regulation of liver glycogen synthetase D phosphatase by ATP and glucoseBiochemical and Biophysical Research Communications, 1973
- Control of rat liver glycogen synthetase and phosphorylase activities by glucoseBiochemical and Biophysical Research Communications, 1970